Free Trial

BeOne Medicines (ONC) Competitors

BeOne Medicines logo
$250.30 -3.09 (-1.22%)
As of 07/11/2025 04:00 PM Eastern

ONC vs. GSK, TAK, ARGX, BNTX, TEVA, INSM, SMMT, ITCI, GMAB, and RDY

Should you be buying BeOne Medicines stock or one of its competitors? The main competitors of BeOne Medicines include GSK (GSK), Takeda Pharmaceutical (TAK), argenex (ARGX), BioNTech (BNTX), Teva Pharmaceutical Industries (TEVA), Insmed (INSM), Summit Therapeutics (SMMT), Intra-Cellular Therapies (ITCI), Genmab A/S (GMAB), and Dr. Reddy's Laboratories (RDY). These companies are all part of the "pharmaceutical products" industry.

BeOne Medicines vs. Its Competitors

BeOne Medicines (NASDAQ:ONC) and GSK (NYSE:GSK) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, analyst recommendations, dividends, valuation, earnings and profitability.

GSK has higher revenue and earnings than BeOne Medicines. BeOne Medicines is trading at a lower price-to-earnings ratio than GSK, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BeOne Medicines$3.81B7.20-$644.79M-$3.72-67.28
GSK$40.10B1.96$3.29B$1.9419.74

BeOne Medicines presently has a consensus target price of $320.67, suggesting a potential upside of 28.11%. GSK has a consensus target price of $37.38, suggesting a potential downside of 2.39%. Given BeOne Medicines' stronger consensus rating and higher possible upside, analysts clearly believe BeOne Medicines is more favorable than GSK.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BeOne Medicines
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
3.00
GSK
1 Sell rating(s)
7 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.11

In the previous week, GSK had 2 more articles in the media than BeOne Medicines. MarketBeat recorded 16 mentions for GSK and 14 mentions for BeOne Medicines. GSK's average media sentiment score of 0.85 beat BeOne Medicines' score of 0.36 indicating that GSK is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BeOne Medicines
3 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
GSK
10 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

BeOne Medicines has a beta of 0.28, suggesting that its stock price is 72% less volatile than the S&P 500. Comparatively, GSK has a beta of 0.5, suggesting that its stock price is 50% less volatile than the S&P 500.

48.6% of BeOne Medicines shares are held by institutional investors. Comparatively, 15.7% of GSK shares are held by institutional investors. 6.6% of BeOne Medicines shares are held by insiders. Comparatively, 10.0% of GSK shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

GSK has a net margin of 9.89% compared to BeOne Medicines' net margin of -9.40%. GSK's return on equity of 48.82% beat BeOne Medicines' return on equity.

Company Net Margins Return on Equity Return on Assets
BeOne Medicines-9.40% -7.55% -4.42%
GSK 9.89%48.82%11.15%

Summary

GSK beats BeOne Medicines on 12 of the 17 factors compared between the two stocks.

Get BeOne Medicines News Delivered to You Automatically

Sign up to receive the latest news and ratings for ONC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ONC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ONC vs. The Competition

MetricBeOne MedicinesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$27.43B$2.42B$5.54B$9.08B
Dividend YieldN/A1.81%5.06%4.03%
P/E Ratio-67.289.2228.2820.33
Price / Sales7.20648.96411.8596.42
Price / CashN/A22.3426.2427.98
Price / Book7.344.638.125.50
Net Income-$644.79M$30.99M$3.19B$250.38M
7 Day Performance3.86%6.64%3.68%2.19%
1 Month Performance-7.17%22.22%7.69%10.92%
1 Year PerformanceN/A-3.88%29.35%16.41%

BeOne Medicines Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ONC
BeOne Medicines
3.4424 of 5 stars
$250.30
-1.2%
$320.67
+28.1%
N/A$27.43B$3.81B-67.2811,000Trending News
Analyst Downgrade
Insider Trade
GSK
GSK
1.7948 of 5 stars
$38.26
-0.6%
$37.38
-2.3%
-2.2%$78.17B$40.10B19.7268,629Gap Down
TAK
Takeda Pharmaceutical
2.1183 of 5 stars
$15.55
+0.8%
N/A+9.2%$48.81B$30.09B70.6949,281
ARGX
argenex
4.429 of 5 stars
$543.32
-0.3%
$728.06
+34.0%
+20.1%$33.18B$2.25B33.521,599Positive News
BNTX
BioNTech
1.6378 of 5 stars
$109.65
+1.3%
$137.86
+25.7%
+32.9%$26.44B$2.98B-32.256,772
TEVA
Teva Pharmaceutical Industries
4.1241 of 5 stars
$17.05
flat
$24.13
+41.5%
-5.2%$19.51B$16.54B-14.8336,830Positive News
INSM
Insmed
4.5405 of 5 stars
$98.50
+0.3%
$106.80
+8.4%
+28.0%$18.55B$363.71M-16.551,271Positive News
SMMT
Summit Therapeutics
2.871 of 5 stars
$24.35
+7.6%
$34.67
+42.4%
+192.4%$18.23B$700K-71.60110High Trading Volume
ITCI
Intra-Cellular Therapies
0.671 of 5 stars
$131.87
flat
$109.70
-16.8%
N/A$14.05B$680.50M-151.57560News Coverage
GMAB
Genmab A/S
3.9892 of 5 stars
$20.41
-0.1%
$37.60
+84.2%
-20.9%$13.02B$3.12B11.602,682Positive News
Analyst Upgrade
RDY
Dr. Reddy's Laboratories
2.7584 of 5 stars
$15.08
+1.3%
$16.95
+12.4%
-8.8%$12.59B$3.81B22.8527,811

Related Companies and Tools


This page (NASDAQ:ONC) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners